Alligator Bioscience AB Reports Full Year Financial Results for 2025 and for Q4 2025 and Provides a Business Update

Rights issue completed: Approximately SEK 91 million (gross) raised in December, strengthening financial position with additional warrant upside in 2026.Mitazalimab validation: OPTIMIZE-1 biomarker results published in Cell Reports Medicine and …